Grand Pharmaceutical Group Limited

MX6A.F

0.55 EUR

1 day: +0.92% (0.00 EUR)

The alert is saved directly without jumping back to the homepage.

Price alerts for MX6A.F

Please log in to view and save price alerts.

Finanzen

Umsatz12.48 Mrd. EUR
EBITDA2.25 Mrd. EUR
Nettogewinn1.11 Mrd. EUR
Market Cap1.99 Mrd. EUR
KGV13.75
Div. Rendite347.00%
52W Hoch1.02 EUR
52W Tief0.48 EUR

Price chart

Loading chart...
Company info

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine, and health food products. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company has a strategic partnership with the University of Hong Kong for the research and development of drugs in the field of anti-infection and the industrialization of the research results. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.

Aktuelle News

Keine aktuellen News verfssgbar.